KH6 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - NewAmsterdam Pharma Company NV

Watchlist Manager

Watchlist

Price: 26.6 EUR 4.19%

Market Cap: €127.3B

N	NewAmsterdam Pharma Company NV F:KH6	NL
	RE Royalties Ltd XTSX:RE	CA
C	Coca-Cola Femsa SAB de CV F:CFSL	MX
	Republic Airways Holdings Inc NASDAQ:RJET	US
A	Aviakompaniya UTair PAO MOEX:UTAR	RU
	Teekay Corp NYSE:TK	BM
	Carel Industries SpA F:CIG	IT
	Metal Powder Works Ltd ASX:MPW	AU

Profitability Summary

NewAmsterdam Pharma Company NV's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-137%

Negative 3Y Average Operating Margin

-137%

Declining Operating Margin

-4% > -137%

Negative Net Margin

-148%

Negative 3Y Average Net Margin

-148%

Declining Net Margin

-80% > -148%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Declining Free Cash Flow Margin

8% > 7%

Negative ROE

-57%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-143%

Declining ROIC

-4% > -143%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-137%

Negative 3Y Average Operating Margin

-137%

Declining Operating Margin

-4% > -137%

Negative Net Margin

-148%

Negative 3Y Average Net Margin

-148%